Have you or your loved ones been diagnosed with carcinoma, transitional cell?

You may qualify to participate in a clinical study to evaluate the new treatment (MitoGel™) for patients suffering from low grade UTUC.

Have you or your loved ones been diagnosed with carcinoma, transitional cell? You may qualify to participate in a clinical study to evaluate the new treatment (MitoGel™) for patients suffering from low grade UTUC.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Carcinoma, Transitional Cell Clinical Trial
NCT02793128 | Phase 3 | Interventional
UroGen Pharma Ltd
Sponsored by
UroGen Pharma Ltd

Have you or your loved ones been diagnosed with carcinoma, transitional cell?

You may qualify to participate in a clinical study to evaluate the new treatment (MitoGel™) for patients suffering from low grade UTUC.

Have you or your loved ones been diagnosed with carcinoma, transitional cell? You may qualify to participate in a clinical study to evaluate the new treatment (MitoGel™) for patients suffering from low grade UTUC.

Completed

Male & Female

18 Years +

This study has recruited 71 Participants

The study is investigating the ability of UroGen's UGN-101 to treat urothelial carcinoma tumors from the upper urinary tract.